Firm is an exception in an industry that has raised few fresh pools of capital this yearOmega Funds, the biotech VC firm founded by brash investor Otello Stampacchia, has raised nearly $650 million to invest in drug startups. The Boston-based firm announced Monday that it has raised $647 million for its eighth fund, exceeding its […]
